Disorders of Carnitine Metabolism (ICD-10-CM Code: E71.4)

Name of the Condition

• Disorders of carnitine metabolism.

Summary

Disorders of carnitine metabolism involve abnormalities in the body's ability to transport or utilize carnitine, a compound essential for fatty acid metabolism and energy production. These conditions can disrupt cellular energy processes, particularly affecting tissues like the heart and muscles, and may lead to systemic complications if untreated.

Causes

These disorders are typically caused by genetic mutations affecting enzymes or transporters involved in carnitine synthesis, transport, or utilization. Inherited in an autosomal recessive pattern, they require mutations in both copies of the relevant gene for clinical manifestation.

Risk Factors

• Family history of carnitine metabolism disorders.
• Consanguinity (parents who are closely related).
• Certain ethnic populations with higher carrier rates for specific mutations.

Symptoms

• Muscle weakness or fatigue.
• Hypotonia (reduced muscle tone).
• Cardiomyopathy (heart muscle disease).
• Recurrent hypoglycemia (low blood sugar).
• Developmental delay or regression.
• Metabolic crises, including hypoketotic hypoglycemia.

Diagnosis

Diagnosis involves biochemical testing to measure carnitine levels in blood or urine, often revealing deficiencies or abnormal ratios. Confirmatory testing may include genetic analysis to identify specific mutations. Newborn screening may detect some forms.

Treatment Options

Treatment focuses on carnitine supplementation to restore levels and manage symptoms. Dietary modifications, such as avoiding prolonged fasting, may be recommended. In severe cases, additional therapies target specific complications, like cardiac or metabolic support.

Prognosis and Follow-Up

Prognosis varies depending on the specific disorder and timeliness of treatment. Early intervention with carnitine supplementation can improve outcomes, but some forms may still lead to progressive muscle or cardiac issues. Regular monitoring of carnitine levels and organ function is essential.

Complications

• Progressive muscle weakness or atrophy.
• Cardiac dysfunction, including heart failure.
• Neurological impairment.
• Metabolic instability, such as hypoglycemia or hypoketosis.
• Growth delays in children.

Lifestyle & Prevention

• Adherence to prescribed carnitine supplementation.
• Avoiding prolonged fasting or strenuous activity without adequate nutrition.
• Regular medical follow-up to monitor organ function.
• Genetic counseling for families with a history of the disorder.

When to Seek Professional Help

Seek immediate medical attention for symptoms like severe muscle pain, difficulty breathing, or signs of metabolic crisis (e.g., confusion, lethargy). Routine care is necessary for ongoing management of chronic symptoms or complications.

Tips for Medical Coders

Document the specific type of carnitine disorder (e.g., primary carnitine deficiency, carnitine transporter defect) when available, as this may influence coding specificity. Ensure clinical documentation supports the diagnosis, including laboratory results or genetic testing, to validate code assignment.